| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | 0.027 | 0.6 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.6 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.014 | 0.6 |